Company News
Glenmark Launches Authorized Generic Axitinib Tablets
Glenmark Pharmaceuticals Inc., USA launched an authorized generic version of INLYTA® (axitinib) tablets in 1 mg and 5 mg strengths.
The U.S. annual sales for INLYTA® Tablets were approximately $538.4